Gene Review:
CYP2C18 - cytochrome P450 2C21
Canis lupus familiaris
Synonyms:
CYP2C19, CYP2C21, CYPIIC21
- Selective inhibition of dog hepatic CYP2B11 and CYP3A12. Lu, P., Singh, S.B., Carr, B.A., Fang, Y., Xiang, C.D., Rushmore, T.H., Rodrigues, A.D., Shou, M. J. Pharmacol. Exp. Ther. (2005)
- Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450. Shou, M., Norcross, R., Sandig, G., Lu, P., Li, Y., Lin, Y., Mei, Q., Rodrigues, A.D., Rushmore, T.H. Drug Metab. Dispos. (2003)
- Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Blaisdell, J., Goldstein, J.A., Bai, S.A. Drug Metab. Dispos. (1998)
- In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes. Kuroha, M., Kuze, Y., Shimoda, M., Kokue, E. Am. J. Vet. Res. (2002)
- mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates. Graham, M.J., Bell, A.R., Crewe, H.K., Moorcraft, C.L., Walker, L., Whittaker, E.F., Lennard, M.S. Xenobiotica (2003)
- Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Paulson, S.K., Engel, L., Reitz, B., Bolten, S., Burton, E.G., Maziasz, T.J., Yan, B., Schoenhard, G.L. Drug Metab. Dispos. (1999)